As of Feb 17
| +0.95 / +1.51%|
The 10 analysts offering 12-month price forecasts for LifePoint Health Inc have a median target of 62.00, with a high estimate of 70.00 and a low estimate of 50.00. The median estimate represents a -2.97% decrease from the last price of 63.90.
The current consensus among 12 polled investment analysts is to Hold stock in LifePoint Health Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.